Founder & CEO
A global pharma-industry veteran with more than 3 decades of experience in managing science and funding, particularly for global clinical development and drug regulatory affairs.
Vice President - Investments Syndication
How to Begin and What Happens Next
Check out our Initial Criteria
1. Your company has a focus on Pharmaceuticals, Bio-Pharmaceuticals, Medical Devices, Nutraceuticals or Cosmeceuticals and you are at Phase II, III or IV of clinical development, or ready to commercialize.
We are particularly excited about Botanicals & 505(b)(2) candidates.
2. Your management team has domain expertise.
3. You are willing to partner with our empanelled CRO for conducting clinical trials or licensing services partner, for which we will provide part funding.
4. You have an exit strategy proposal for us.
Write us an EMail
Tell us everything you would like to share to bring us up on your ideas in an initial email. Do include an executive summary & investor presentation.
Be as succinct & explicit as possible.
Our techno-commercial evaluation process would obviously need information about your product, team, operations strategy, financial projections & exit strategy.
Our team will perhaps ask you for some additional information.
If your idea excites us - we'll schedule a Phone Call or Video Conference.
Phone or Video Conference
We'll have an initial discussion to further understand your business idea, get to know each other better and explore how to get to the next steps.
You could take this opportunity to present your overall vision, financials, IP, corporate road map and fund raising goals.
We would suggest that you include your entire core team for this session.
A lot of distance gets traveled when we are actually together in a room!
Due Diligence & Finalization
If everything looks good to both parties - we'd proceed with the paperwork and embark upon our journey with you.